Solbar Ningbo Protein Technology Co., Ltd. Class A

Solbar Ningbo Protein Technology Co., Ltd. Class A

SSSE:603231
16.53
CNY
-0.08
(-0.48%)
0.74EPS
22.97P/E
3.30BMarket Cap
Apr 19Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
9.18
8.89
11.01
12.86
12.22
8.09
9.12
10.32
Basic EPS, GAAP
0.57
0.68
0.86
1.17
1.02
0.63
0.99
0.75
Free Cash Flow per Basic Share
0.05
0.87
0.01
0.29
0.31
-0.11
0.63
- -
Dividend per Share
0.32
0.21
0.51
0.44
0.32
0.5
0.3
0.38
Book Value per Share
3.87
4.42
4.79
5.59
10.1
9.79
10.48
10.63
Tangible Book Value per Share
3.72
4.18
4.46
5.27
9.79
9.47
10.17
10.33
Basic Weighted Avg Shares
116
144
144
144
143
192
192
190
Sales/Revenue/Turnover
1,063
1,279
1,586
1,847
1,748
1,555
1,748
1,965
Operating Margin (%)
8.43
10.05
10.29
10.12
10.37
7.93
12.52
9.08
Depreciation Expense
43
44
45
54
64
70
78
- -
Net Income, GAAP
66
98
124
168
146
121
190
143
Effective Tax Rate (%)
18.66
18.24
13.05
11.01
15.25
15.89
15.15
15.25
Profit Margin (%)
6.21
7.64
7.81
9.1
8.35
7.79
10.85
7.28
Working Capital
211
272
190
191
1,253
1,106
1,119
1,136
LT Debt
- -
- -
- -
- -
- -
- -
- -
2
Total Equity
556
634
688
803
1,934
1,874
2,007
2,036
Return on Invested Capital (%)
- -
14.94
17.64
20.12
10.48
6.36
9.78
- -
Return on Capital (%)
- -
15.81
18.01
21.2
10.19
6.19
9.66
- -
Return on Common Equity (%)
- -
16.42
18.74
22.54
10.67
6.36
9.78
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
24
65
195
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
191
191
191
Market Capitalization
3,306
2,834
3,305

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,353
1,410
1,486
Cash, Cash Equivalents & STI
881
833
847
Accounts Receivable, Net
139
160
170
Inventories
235
329
367
Total Current Liabilities
217
260
350
Payables & Accruals
- -
- -
- -
ST Debt
24
65
195
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
34.01%
7.06%
Free Cash Flow
- -
466.19%
-681.57%
Net Income, GAAP
- -
17.76%
56.56%
Sales/Revenue/Turnover
- -
7.3%
12.39%
Total Cash Common Dividend
- -
35.26%
-40.05%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
393
379
383
400
1,555
2025
392
382
- -
508
1,748
2026
488
479
490
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.19
0.18
0.11
0.15
0.63
2025
0.23
0.28
- -
0.22
0.99
2026
0.17
0.19
0.17
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.5
- -
- -
0.5
2025
- -
0.3
- -
- -
0.3
2026
0.07
0.3
- -
- -
- -

Company Description

CEO
Yong Heng Dai
Full Time Employees
947
Sector
Process industries
Industry
Agricultural commodities/Milling
Address
No. 12 Xingye Road Ningbo ZH China 315800
IPO Date
Dec 15, 2023
Website
solbar.com
Business
Solbar Ningbo Protein Technology Co., Ltd. (603231.SS) manufactures and markets soy protein products for applications in food and beverages, nutritional supplements, and dietary supplements. The company produces functional soy protein concentrates, textured soy protein concentrates including texturized soy protein concentrate and textured fibrous vegetable protein, isolated soy protein, non-functional concentrated protein; it also offers brands such as Solbar, Wonderful, Contex, Solcon, Soytex, and Solpro. Founded in October 2003 and headquartered in Ningbo Free Trade Zone, China, Solbar Ningbo inherits production technology from Israel's Solbar and innovation from the Wonderful Industrial Group, processing non-GMO soybeans with complete production lines from low-temperature extraction to customized proteins. The company operates primarily in China and exports to over 50 countries via distributors and direct sales to multinational customers in Asia and overseas markets. In September 2023, Solbar Ningbo announced a new partnership to expand its distribution network; in the third quarter of 2024, it launched a facility expansion to meet rising demand for soy protein isolates and related products.